Home/Filings/4/0000904314-18-000003
4//SEC Filing

WEIL JOHN D 4

Accession 0000904314-18-000003

CIK 0000874710other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 11:06 AM ET

Size

23.5 KB

Accession

0000904314-18-000003

Insider Transaction Report

Form 4
Period: 2018-11-08
WEIL JOHN D
Director10% Owner
Transactions
  • Award

    Option (right to buy)

    2018-11-08+750750 total
    Exercise: $2.13From: 2019-11-08Exp: 2028-11-08Common Stock (750 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    60,520
  • Common Stock

    (indirect: By Partnership)
    137,736
  • Option (right to buy)

    Exercise: $2.22From: 2018-11-09Exp: 2027-11-09Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $2.34From: 2016-11-12Exp: 2025-11-12Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $3.16From: 2015-11-13Exp: 2024-11-13Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $8.10From: 2009-11-13Exp: 2018-11-13Common Stock (750 underlying)
    750
  • Common Stock

    90,513
  • Common Stock

    (indirect: By Spouse)
    94,427
  • Common Stock

    (indirect: By Trust)
    59,101
  • Option (right to buy)

    Exercise: $4.62From: 2014-11-14Exp: 2023-11-14Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $5.18From: 2013-11-08Exp: 2022-11-08Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $7.10From: 2012-11-10Exp: 2021-11-10Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $8.68From: 2011-11-11Exp: 2020-11-11Common Stock (750 underlying)
    750
  • Common Stock

    (indirect: By IRA)
    2,500
  • Common Stock

    (indirect: Corporation)
    7,927
  • Option (right to buy)

    Exercise: $2.26From: 2017-11-10Exp: 2026-11-10Common Stock (750 underlying)
    750
  • Option (right to buy)

    Exercise: $10.08From: 2010-11-13Exp: 2019-11-13Common Stock (750 underlying)
    750
Footnotes (6)
  • [F1]Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economical benefit in such shares.
  • [F2]The reporting person disclaims any economic benefit in such shares.
  • [F3]Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
  • [F4]Owned by a corporation controlled by the reporting person.
  • [F5]Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
  • [F6]Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.

Issuer

ALLIED HEALTHCARE PRODUCTS INC

CIK 0000874710

Entity typeother
IncorporatedMO

Related Parties

1
  • filerCIK 0000904314

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 11:06 AM ET
Size
23.5 KB